Form 4: Director J. Paul Abernathy Receives NHC Stock Option Grant
Statement of Changes in Beneficial Ownership
National HealthCare Corp director J. Paul Abernathy was granted 7,500 stock options as part of the company's 2020 Omnibus Equity Incentive Plan.
Summary
- Director J. Paul Abernathy received a grant of 7,500 stock options for National HealthCare Corp (NHC) common stock.
- The options were granted on May 7, 2026, with an exercise price of $171.42 per share.
- The options vest on May 7, 2027, and have an expiration date of May 6, 2031.
- Following this transaction, the director maintains direct beneficial ownership of 43,302 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation with no material impact on company operations.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- None noted.
Risks
- Market volatility affecting the value of equity-based compensation.
- Potential dilution of existing shareholders upon the future exercise of these options.
Future Outlook
The filing does not provide forward-looking financial guidance, as it is a disclosure of director equity compensation.
Industry Context
StockSavvy.ai notes that equity grants to directors are standard corporate governance practices in the healthcare services sector to ensure long-term alignment with shareholder interests.
Comparison to Industry Standards
- The use of an Omnibus Equity Incentive Plan is consistent with standard compensation practices for publicly traded healthcare companies.
- The vesting schedule and exercise pricing are typical for executive and director compensation packages in the U.S. healthcare industry.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Grant of stock options under the 2020 Omnibus Equity Incentive Plan. | 05/07/2026 | Standard alignment of director compensation with shareholder interests. |
Stakeholder Impact
- Shareholders may experience minor dilution if these options are exercised in the future.
Next Steps
- Vesting of the granted options on May 7, 2027.
Key Dates
| Date | Description |
|---|---|
| 05/07/2026 | Grant date of stock options and date of filing. |
| 05/07/2027 | Vesting date for the 2026 option grant. |
| 05/06/2031 | Expiration date for the 2026 option grant. |
Keywords
National HealthCare Corp, NHC, Form 4, Insider Trading, Stock Options, Equity Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.